Omaxe Ltd.

₹69.95

4.7 (7.2%)

OMAXE Share Price

Realty

As on April 1, 2026

SectorRealty

IndustryRealty

Basic IndustryResidential Commercial Projects

Market Cap₹ 1,282 Cr

P/E Ratio-1.86

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	68.85	Bullish
10-DMA	70.02	Bearish
20-DMA	72.21	Bearish
50-DMA	75.15	Bearish
100-DMA	74.25	Bearish
200-DMA	83.04	Bearish

Historical Performance

1 Year

-12.7%

3 Years

40.7%

5 Years

2.2%

10 Years

-51.9%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Operating Expenses	139	122	100	61	48
Other Income	760	206	247	201	389
Operating Profit	-5,318	-3,227	-2,786	-267	-798
Interest	1,953	1,303	1,128	1,211	1,614
Depreciation	367	543	654	466	634
Profit Before Tax	-7,638	-5,073	-4,568	-1,944	-3,046
Consolidated Net Profit	-6,860	-4,026	-3,479	-1,595	-2,352
Adjusted EPS	-38	-22	-19	-9	-13

Compounded Sales Growth

10 Years:2.4

5 Years:6.8

3 Years:20.4

TTM:-0.7

Compounded Profit Growth

10 Years:25.4

5 Years:47.8

3 Years:33.9

TTM:11.2

Stock Price CAGR

10 Years:-7.1

5 Years:0.4

3 Years:12.1

TTM:-11.5

Return on Equity

10 Years:4.2

5 Years:-12.9

3 Years:-19

last year:-37.5

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	1,829	1,829	1,829	1,829	1,829
Total Reserves	-3,880	2,975	7,153	10,621	12,218
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	5,190	6,196	7,633	6,362	9,765
Other Current Liabilities	1,25,802	1,10,320	1,02,591	86,267	71,909
Short Term Borrowings	301	190	163	799	1,576
Total Liabilities	1,42,763	1,33,028	1,31,463	1,16,121	1,08,255
Capital Work in Progress	---	---	---	---	---
Long Term Loans & Advances	2,817	1,882	1,578	1,768	2,294
Currents Investments	---	---	---	---	---
Short Term Loans and Advances	10,640	9,876	9,774	7,708	6,250
Total Current Assets	1,32,457	1,24,584	1,22,975	1,07,348	98,893
Total Assets	1,42,763	1,33,028	1,31,463	1,16,121	1,08,255
Adjusted Book Value	-11	26	49	68	77

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a low PE of -1.86, which may indicate undervaluation or subdued growth expectations.
Over the last three years, the stock delivered a moderate 3-year price CAGR of 11.3%, reflecting average market performance.
The stock carries a beta of 1.2, indicating volatility broadly in line with the market.
In the last financial year, the company reported a negative or negligible EBITDA of ₹-5318 million, indicating weak operating profitability.
In the previous financial year, the company generated revenue of ₹15610 million, indicating a large and established business.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 885331

No. of Shares: 12657 (Approx)

Performance:-11.5%

P/L: ₹-114669

NIFTY Performance: -2.8%

1 day Top Gainers

Symbol	Change%
GRSE	2359.3(20%)
OLAELEC	25.89(14%)
MAZDOCK	2318.2(12%)
TTML	35.19(12%)
COCHINSHIP	1338.6(12%)

1 Day Top Losers

Symbol	Change%
IPCALAB	1508.2(-6%)
DRREDDY	1209.6(-4%)
HYUNDAI	1716.2(-4%)
BLUESTARCO	1556.3(-3%)
ASHOKLEY	149.11(-3%)
HDFCLIFE	572.95(-3%)
BHARTIHEXA	1465.6(-3%)
JBCHEPHARM	2008.8(-3%)